AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea · Delayed Price · Currency is KRW 7,700.00
-240.00 (-3.02%)
At close: Feb 6, 2026
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 216.32 billion as of February 6, 2026. Its market cap has increased by 15.45% in one year.
Market Cap
216.32B
Enterprise Value
205.54B
Revenue
3.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,700.00
Market Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 216.32B, a decrease of -48.90%. That is a compound annual growth rate of -9.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 216.32B | -13.93% |
| Dec 30, 2025 | 251.34B | 46.78% |
| Dec 30, 2024 | 171.23B | -15.15% |
| Dec 28, 2023 | 201.80B | -15.02% |
| Dec 29, 2022 | 237.48B | -71.24% |
| Dec 30, 2021 | 825.71B | 46.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suheung | 249.07B |
| Daewon Pharmaceutical | 244.13B |
| Chong Kun Dang Holdings | 235.65B |
| Samjin Pharmaceuticals | 235.35B |
| Ilyang Pharmaceutical Co.,Ltd | 233.92B |
| HLB Pharmaceutical | 228.19B |
| REYON Pharmaceutical | 212.57B |
| Jeil Pharmaceutical Co.,Ltd | 211.29B |